Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1328-1336

  Miyoshi, Kazuhisa ^a   Kanda, Atsuhiro ^a   Nozawa, Yoshihisa ^a   Nakano, Motoko ^a   Miyake, Hidekazu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARANIDIPINE; DIHYDROPYRIDINE DERIVATIVE; MANIDIPINE; NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; HYPERTENSION; INTESTINE BLOOD FLOW; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; LUNG BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MUSCLE BLOOD FLOW; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STOMACH BLOOD FLOW; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; HEART RATE; HYPERTENSION; MALE; NIFEDIPINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0030435120     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. BAUER, J. H. AND REAMS, G.: Short- and long-term effects of calcium entry blockers on the kidney. Am. J. Cardiol. 59: 66A-71A, 1987.
2. BELL, A. J. AND LINDNER, A.: Effects of verapamil and nifedipine on renal function and hemodynamics in the dog. Renal Physiol. 7: 329-343, 1984.
3. BOLT, G. R. AND SAXENA, P. R.: Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits. J. Cardiovasc. Pharmacol. 6: 707-712, 1984.
4. DIETZ, J. R., DAVIS, J. O., FREEMAN, R. H., VILLAHREAL, D. AND ECHTENKAMP, S. F.: Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs. Hypertension 5: 482-488, 1983.
5. DREXLER, H., TRUOG, A. G., ZEUS, R. AND FLAIM, S. F.: Regional vascular and hemodynamic effects of orally administered nisoldipine in conscious rats. J. Cardiovasc. Pharmacol. 8: 151-155, 1986.
6. DUNN, O. J.: Multiple comparisons among means. J. Am. Statist. Assoc. 56: 52-64, 1961.
7. FLECKENSTEIN, A.: Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 17: 149-166, 1977.
8. GODFRAIND, T., MILLER, R. AND WIBO, M.: Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 38: 321-416, 1986.
9. GRAHAM, R. M., PETTINGER, W. A., SAGALOWSKY, A., BRABSON, J. AND GANDLER, T.: Renal alpha-adrenergic receptor abnormality in the spontaneously hypertensive rat. Hypertension 4: 881-887, 1982.
10. HEYMANN, M. A., PAYNE, B. D., HUFFMAN, J. I. E. AND RUDOLPH, A. M.: Blood flow measurements with radionuclide-labeled particles. Prog. Cardiovasc. Res. 20: 55-79, 1977.
11. HOF, R. P.: Selective effects of different calcium antagonists on the peripheral circulation. Trends Pharmacol. Sci. 5: 100-102, 1984.
12. 2+ entry blocker, on α-adrenoceptor-mediated pressor responses in pithed rats. Eur. J. Pharmacol. 238: 283-289, 1993.
13. ISHII, H., ITOH, K. AND NOSE, K.: Different antihypertensive effect of nifedipine in conscious experimental hypertensive and normotensive rats. Eur. J. Pharmacol. 64: 21-29, 1980.
14. KANDA, A., HAHUNO, A., MIYAKE, H. AND NAGASAKA, M.: Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs. J. Cardiovasc. Pharmacol. 20: 723-730, 1992.
15. KANDA, A., HARUNO, A., MIYOSHI, K., TANAHASHI, Y., MIYAKE, H., ICHIHARA, K., OKUMURA, K. AND NAGASAKA, M.: Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: Comparison with other calcium antagonists. J. Cardiovasc. Pharmacol. 22: 167-175, 1993.
16. KANDA, K. AND FLAIM, S. F.: Effects of nifedipine on total cardiac output distribution in conscious rat. J. Pharmacol. Exp. Ther. 228: 711-718, 1984.
17. KNIGHT, D. R, KIRBY, D. A. AND VATNER, S. F.: Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs. Hypertension 7: 380-385, 1985.
18. LANGER, S. L. AND HICKS, P. E.: Alpha-adrenoceptor subtypes in blood vessels: Physiology and pharmacology. J. Cardiovasc. Pharmacol. 6: Suppl. 4, S547-S558, 1984.
19. LOUTZENHISER, R. AND EPSTEIN, M.: Effects of calcium antagonists on renal hemodynamice. Am. J. Physiol. 249: F619-F629, 1985.
20. MEDGETT, I. C., HICKS, P. E. AND LANGER, S. Z.: Smooth muscle alpha-2 adrenoceptora mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar-Kyoto rat tail arteries. J. Pharmacol. Exp. Ther. 231: 159-165, 1984.
21. MICHEL, M. C., INSEL, P. A. AND BRODDE, O.-E.: Renal α-adrenergic receptor alterations: A cause of essential hypertension? Fed. Am. Soc. Exp. Biol. J. 3: 139-144, 1989.
22. MIYOSHI, K., KANDA, A., MIYAKE, H., ICHLHARA, K., KAMEI, H. AND NAGASAKA, M.: MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action. Eur. J. Pharmaeol. 238: 139-148, 1993.
23. MURPHY, M. B., SCRIVEN, A. J. AND DOLLERY, C. T.: Role of nifedipine in treatment of hypertension. Br. Med. J. Clin. Res. 287: 257-259, 1983.
24. NAGAOKA, A., SHIBOTA, M. AND HAMAJO, K.: Effects of a new dihydropyridine derivative, CV-4093 · 2HCl, on renal hemodynamics in spontaneously hypertensive rats. Jpn. J. Pharmacol. 51: 25-35, 1989.
25. NAKAYA, H., HATTORI, Y., NAKAO, Y. AND KANNO, M.: Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists. Eur. J. Pharmacol. 146: 35-43, 1988.
26. NIWA, K., SHIGEMATSU, K., MAEDA, T., FUJIMOTO, M., YAMASHITA, K., KATAOKA, Y. AND TANIYAMA, K.: Effects of MPC-1304, a novel calcium antagonist, on stroke-prone spontaneously hypertensive rate. Arch. Int. Pharmacodyn. Ther. 327: 309-329, 1994.
27. NORDLANDER, M.: Hemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats. Drugs 29: Suppl. 2, 90-101, 1985.
28. NOSAKA, S. AND WANG, S.: Carotid sinus baroreceptor functions in the spontaneously hypertensive rat. Am. J. Physiol. 222: 1079-1084, 1972.
29. OHNO, S., KOMATSU, O., MIZUKOSHI, K., ICHIHARA, K., NAKAMURA, Y., MORISHIMA, T. AND SUMITA, K.: Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3, 5-pyridinecarboxylates with vasodilating and antihypertensive activities. Chem. Pharmacol. Bull. 34: 1589-1606, 1986.
30. PEGRAM, B. L., KOBRIN, I., SESOKO, S. AND FROHLICH, E. D.: Nitrendipine: Hemodynamic effects in conscious normotensive and spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 6: Suppl. 7, S1016-S1023, 1984.
31. 2-adrenergic receptor regulation in genetically hypertensive rate. Hypertension 4: Suppl. II, II188-II192, 1982.
32. PFEFFER, M. AND FROHLICH, E.: Hemodynamics of spontaneously hypertensive rats. Am. J. Physiol. 224: 1066-1071, 1973.
33. SAINI, R. K. AND SOMANI, P.: Hemodynamic and regional blood flow studies in the normotensive and spontaneously hypertensive rat: Application of the radioactive microsphere technique. J. Pharmacol. Methods 2: 357-369, 1979.
34. SAIZ, J., LARA, B., TORRES, A. AND SANCHEZ, A.: Hypertensinogenic factors and renal α-adrenoceptors in young SHR and WKY rats. Life Sci. 41: 2261-2268, 1987.
35. SANCHEZ, A., VIDAL, M. J., MARTINEZ-SIERRA, R. AND SAIZ, J.: Ontogeny of renal alpha-1 and alpha-2 adrenoceptors in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 237: 972-979, 1986.
36. SAPRU, N. AND WANG, S.: Modification of aortic baroreceptor resetting in the spontaneously hypertensive rat. Am. J. Physiol. 230: 664-674, 1976.
37. SCHMITZ, J. M., GRAHAM, R. M., SAGALOWSKY, A. AND PETTINGER, W. A.: Renal alpha-1 and alpha-2 adrenergic receptors: Biochemical and pharmacological correlations. J. Pharmacol. Exp. Ther. 219: 400-406, 1981.
38. SESOKO, S., PEGRAM, B. L. AND FROHLICH, E. D.: Systemic and regional hemodynamics in normotensive and spontaneously hypertensive rats after slow-channel calcium blocker nitrendipine. Clin. Exp. Hypertens. 6: 979-991, 1984.
39. SNAVELY, M. D. AND INSEL, P. A.: Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Mol. Pharmacol. 22: 532-546, 1982.
40. SORKIN, E. M., CLISSOLD, S. P. AND BROGDEN, R. N.: Nifedipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 30: 182-274, 1985.
41. STRUYKER-BOUDIER, H. A. J., DE MEY, J. G., SMITHS, J. F. M. AND NIEVELSTEIN, H. M. N. W.: Hemodynamic actions of calcium entry blockers. Prog. Basic Clin. Pharmacol. 2: 21-66, 1989.
42. 1-adrenoceptor-mediated vasoconstriction in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 324: 239-245, 1983.
43. VAN ZWIETEN, P. A., VAN MEEL, J. C. A. AND TIMMERMANS, P. B. M. W. M.: Pharmacology of calcium entry blockers: Interaction with vascular alpha-adrenoceptors. Hypertension 5: Suppl. II, II8-II17, 1983a.
44. 2-adrenocePtors. Circ. Res. 52: Suppl. I, I177-I180, 1983b.
45. WAGNER, H. N., RHODES, B. A., SASAKI, Y. AND RYAN, J. P.: Studies of the circulation with radioactive microspheres. Invest. Radiol. 4: 374-386, 1969.
46. 2-adrenoceptor mediated vasoconstriction in dogs: Comparison of phenylephrine, clonidine, and guanabenz. J. Cardiovasc. Pharmacol. 6: Suppl. 5, S793-S798, 1984.
47. YOSHIDA, K, MITANI, M., TSUKAMOTO, T., NAESHIRO, I., SHIRAISHI, A., YAGI, K., KIMURA, T., SHIMOMURA, H. AND TANAYAMA, S.: Disposition of manidipine hydrochloride [CV-4093 (2HCl)], a new calcium antagonist, in rats and dogs. Jpn. Pharmacol. Ther. 17: 2083-2117, 1989.